Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin. | Nat Commun | 2022 | 36050397 | PubTator, text mining | PubMed |
| Decoding mechanism of action and sensitivity to drug candidates from integrated transcriptome and chromatin state. | Elife | 2022 | 36043458 | PubTator, text mining | PubMed |
| Activation of recombinational repair in Ewing sarcoma cells carrying EWS-FLI1 fusion gene by chromosome translocation. | Sci Rep | 2022 | 36042341 | PubTator, text mining | PubMed |
| Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice. | Clin Cancer Res | 2022 | 36040493 | PubTator, text mining | PubMed |
| Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas. | Genome Med | 2022 | 36038884 | PubTator, text mining | PubMed |
| Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation. | Front Pharmacol | 2022 | 36034850 | PubTator, text mining | PubMed |
| Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. | J Pers Med | 2022 | 36013219 | PubTator, text mining | PubMed |
| The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer. | Int J Mol Sci | 2022 | 36012581 | PubTator, text mining | PubMed |
| Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma. | Int J Mol Sci | 2022 | 36012262 | PubTator, text mining | PubMed |
| Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma. | Genes (Basel) | 2022 | 36011309 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts. | Cancers (Basel) | 2022 | 36010906 | PubTator, text mining | PubMed |
| BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside. | Cancers (Basel) | 2022 | 36010882 | PubTator, text mining | PubMed |
| Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients. | Cells | 2022 | 36010660 | PubTator, text mining | PubMed |
| Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. | Cells | 2022 | 36010595 | PubTator, text mining | PubMed |
| Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors. | Diagnostics (Basel) | 2022 | 36010253 | PubTator, text mining | PubMed |
| Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease. | Biomedicines | 2022 | 36009418 | PubTator, text mining | PubMed |
| Long non‑coding RNAs interact with RNA‑binding proteins to regulate genomic instability in cancer cells (Review). | Oncol Rep | 2022 | 36004472 | PubTator, text mining | PubMed |
| Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease. | Cell Rep | 2022 | 36001971 | PubTator, text mining | PubMed |
| Muscle and Bone Defects in Metastatic Disease. | Curr Osteoporos Rep | 2022 | 35994202 | PubTator, text mining | PubMed |
| Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes. | Ann Med | 2022 | 35993327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=48